Tilt Hldgs Inc - TLLTF STOCK NEWS

TILT Holdings reported its Q1 2024 financial results, revealing a revenue of $37.5 million, down from $42.3 million in Q1 2023 due to lower sales volumes and price compression in Massachusetts and Pennsylvania. The gross profit stood at $6.7 million with a margin of 17.9%, compared to $8.8 million and 20.8% respectively from the previous year. The net loss widened to $9.7 million, primarily due to a reduced gross profit and no asset sales gains as in Q1 2023. Adjusted EBITDA improved slightly to $38,000 from $(79,000). Operational highlights included the launch of the Level brand in Pennsylvania and winning the NECANN Cup for best vape cartridge. TILT is focusing on strengthening its balance sheet and addressing debt in 2024, despite ongoing industry challenges.

TILT Holdings Inc. secures funding for its Pennsylvania subsidiary, Standard Farms, to develop and operate three medical marijuana dispensaries in the Commonwealth of Pennsylvania under a new permit. The funding, up to $10.5 million, is provided by an experienced retailer and operator. The Note will bear interest at 20% initially, increasing to 30% and then 40% as milestones are achieved. The loan is secured by Standard Farms' retail assets and equity interests held by Baker Technologies, Inc.

TILT Holdings Inc. announces its first-quarter 2024 conference call scheduled for May 15, 2024, at 5:00 p.m. ET to discuss business strategy and financial results. TILT, a global cannabis solutions provider, will report its results and host a Q&A session.

TILT Holdings Inc. CEO, Tim Conder, is set to speak at the Benzinga Cannabis Capital Conference in Florida, discussing consumer demand in the cannabis industry. The event will feature industry experts exploring the relationship between product offerings and consumer demand.

TILT Holdings Inc. subsidiary Standard Farms wins first place for best vape cartridge in the 2024 NECANN Cup with the Mimosa Liquid Live Rosin 'All-in-One' Vape, showcasing industry leadership in product and hardware innovation.

TILT Holdings Inc. reports financial and operational results for Q4 and FY 2023, showcasing revenue decline, cost-saving initiatives, brand partnerships, and debt restructuring. Despite challenges, the company focuses on efficiency, debt reduction, and revenue growth in 2024.

TILT Holdings Inc. partners with LEVEL to distribute infused tablets in Pennsylvania, expanding offerings for medical cannabis patients. The tablets are portable, discreet, and offer precise dosing. TILT plans to launch LEVEL's PROTABTM and PROTAB 100TM in April, with future plans for cannabinoid-enhanced tablets. These vegan, gluten-free tablets provide a long-lasting effect, making them ideal for medical use.

TILT Holdings Inc. (TLLTF) will host a conference call to discuss its Q4 and FY 2023 financial results, including business strategy updates. The call will take place on March 14, 2024, at 5:00 p.m. ET. Interested parties can join the call and access the webcast for further details.

TILT Holdings Inc. and its subsidiary Jupiter Research have launched THREDZ™, a stackable cartridge technology that allows consumers to create personalized cannabis blends. The innovative technology enables users to combine two oil cartridges to customize their smoking experience with various cannabinoid and terpene combinations. This new product aims to cater to the growing demand for customizable cannabis consumption, providing a unique and portable solution for consumers. THREDZ cartridges are designed to work with existing 510 batteries, offering a sustainable and cost-effective option for users. TILT Holdings continues to focus on providing innovative solutions to enhance consumer experiences in the cannabis industry.